Education
About Us
Working with TipRanks
Follow Us
Gary Hattersley Insider Profile
4 Followers
Gary Hattersley, CSO at Radius Health, holds 0.00 shares in Nuvation Bio (Ticker: NUVB), holds 0.00 shares in Radius Health (Ticker: ~RDUS).
Gary Hattersley Radius Health (~RDUS)CSO
Radius Health (~RDUS)
CSO
Not Ranked
Gary Hattersley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Gary Hattersley does not currently own shares as a corporate insider.
A breakdown of Gary Hattersley's holdings
Insider Roles
CSO
Roles that Gary Hattersley holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gary Hattersley
Gary Hattersley's Trading History
Radius Health
Nov 13, 2015
―
Uninformative Sell
426.23K
$0.00
Nuvation Bio
Nov 24, 2025
CSO
Uninformative Buy
702.15K
$0.00
List of latest transactions for each holding click on a transaction to see Gary Hattersley's performance on stock
You May Also Like
Gary Hattersley insider profile FAQ
What is the percentage of profitable transactions made by Gary Hattersley?
The percentage of profitable transactions made by Gary Hattersley is ―.
What is the average return per transaction made by Gary Hattersley?
The average return per transaction made by Gary Hattersley is ―.
What stocks does Gary Hattersley hold?
Gary Hattersley holds: ~RDUS, NUVB stocks.
What was Gary Hattersley’s latest transaction?
Gary Hattersley latest transaction was an Uninformative Buy of $702.15K.
What was Gary Hattersley's most profitable transaction?
Gary Hattersley’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gary Hattersley's role in Radius Health?
Gary Hattersley's role in Radius Health is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.